Patent details

Basic Information

Publication number:

EP2768522

PCT Application Number:

PCT/EP/2012/070615

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127778959

PCT Publication Number:

WO/2013/057167

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF SULFATED GLYCOSAMINOGLYCANS FOR IMPROVING THE BIOAVAILABILITY OF FACTOR VIII

French Title of Invention:

UTILISATION DE GLYCOSAMINOGLYCANES SULFATÉS POUR AMÉLIORER LA BIODISPONIBILITÉ DES FACTEURS DE COAGULATION SANGUINE

German Title of Invention:

VERWENDUNG SULFATIERTER GLYCOSAMINGLYCANE ZUR VERBESSERUNG DER BIOVERFÜGBARKEIT VON BLUTGERINNUNGSFAKTOREN

SPC Number:

Dates

Filing date:

18/10/2012

Grant date:

27/07/2016

EP Publication Date:

27/07/2016

PCT Publication Date:

25/04/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/08/2014

EP B1 Publication Date:

27/07/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/10/2016

Expiration date:

18/10/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/10/2012

 

 

Name:

CSL Behring GmbH

Address:

Emil-von-Behring-Strasse 76, 35041 Marburg, Germany (DE)

Inventor

1

Name:

ZOLLNER Sabine.

Address:

Switzerland (CH)

2

Name:

METZNER Hubert.

Address:

Germany (DE)

Priority

1

Priority Number:

201161548606

Priority Date:

18/10/2011

Priority Country:

United States (US)

2

Priority Number:

11185648

Priority Date:

18/10/2011

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 38/36;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages